Patents by Inventor James Burke

James Burke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY
    Publication number: 20150104491
    Abstract: The present invention provides a sustained release implant for intraocular use to treat elevated intraocular pressure, which implant is configured for intracameral or anterior vitreal administration to a patient with elevated intraocular pressure (IOP), said implant comprising a core of an antihypertensive agent surrounded by a polymer, which limits the rate of passage of the antihypertensive agent from the implant into the eye of said patient and said implant provides a linear rate of release of therapeutically effective amounts of said anti-hypertensive agent into the eye for a period of time of between 14 days and 365 days.
    Type: Application
    Filed: September 10, 2014
    Publication date: April 16, 2015
    Inventors: Ruiwen Shi, Patrick M. Hughes, James A. Burke, Michael R. Robinson, Hui Liu
  • Biodegradable drug delivery system
    Patent number: 8956655
    Abstract: A drug delivery system (DDS) comprised of segmented biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The segmented implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer, and permit the DDS to have segments that possess individual and different drug release characteristics.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: February 17, 2015
    Assignee: Allergan, Inc.
    Inventors: Robert T. Lyons, James A. Burke, Michael R. Robinson
  • Method and apparatus for photothermal treatment of tissue at depth
    Patent number: 8915948
    Abstract: The present invention provides method and apparatus for treating tissue in a region at depth by applying optical radiation thereto of a wavelength able to reach the depth of the region and of a selected relatively low power for a duration sufficient for the radiation to effect the desired treatment while concurrently cooling tissue above the selected region to protect such tissue. Treatment may be enhanced by applying mechanical, acoustic or electrical stimulation to the region.
    Type: Grant
    Filed: February 15, 2008
    Date of Patent: December 23, 2014
    Assignees: Palomar Medical Technologies, LLC, The General Hospital Corporation
    Inventors: Gregory B. Altshuler, Andrei V. Erofeev, Henry Zenzie, Richard Rox Anderson, Dieter Manstein, James Burke, III, Andrew Radl, Michael Z. Smirnov
  • Clothing Style Selection and Matching E-Commerce & Game Interface
    Publication number: 20140358737
    Abstract: A clothing style selection display image includes, first and second windows enabling a user to select a top dress item and a bottom dress item respectively and a match zone. The match zone presents a selected top dress item and a bottom dress item adjacent, in response to user selection of the selected top dress item and the selected bottom dress item in the first and second windows respectively. In a clothing style selection and matching game embodiment, the display image presents an indicator of degree of match of dress items in the match zone with a winner having best match. In another game embodiment, the display image presents multiple different match zones with a winner matching dress items in the multiple different match zones fastest. The match zone presents the selected top dress item and the bottom dress item with substantially matching waist size.
    Type: Application
    Filed: May 26, 2014
    Publication date: December 4, 2014
    Inventor: Alexander James Burke
  • Secure Network Communications for Meters
    Publication number: 20140344915
    Abstract: A system and method are provided for secure network communications. A proxy server receives meter data, from a meter of a set of meters via a local network, for an energy management server. The proxy server uses secure communications to send the meter data via a non-secure network to the energy management server.
    Type: Application
    Filed: August 1, 2014
    Publication date: November 20, 2014
    Inventors: Robert James Burke, Prateek Sangal, Robert Daniel Maher, III
  • METHOD FOR TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION
    Publication number: 20140322206
    Abstract: Compositions and methods for treating dry age related macular degeneration (dry AMO) by administration to an intraocular location of an anti-neovascular agent (such as bevacizumab) in either a liquid or solid polymeric vehicle (or both), such as a biodegradable hyaluronic acid or PLGA (or PLA).
    Type: Application
    Filed: July 7, 2014
    Publication date: October 30, 2014
    Inventors: Scott M. Whitcup, Michael R. Robinson, Wendy M. Blanda, Patrick M. Hughes, James A. Burke
  • Supplementary energy starting system incorporating a timing circuit
    Patent number: 8820287
    Abstract: An engine cranking system and a method of cranking an engine are provided. The engine cranking system comprises an engine, cranking motor, and capacitor. The engine cranking system further comprises an electrical path interconnecting the cranking motor or a battery to the capacitor. The engine cranking system further comprises a control circuit coupled to the capacitor. The control circuit comprises a timer operative to track temporal information. The control circuit is operative to apply a control voltage that varies in response to the tracked temporal information. The control circuit further comprises a relay included in the electrical path. The relay is operative to switch, in response to the control voltage, between an open-circuit condition, in which the relay interrupts the electrical path, and a closed-circuit condition.
    Type: Grant
    Filed: February 20, 2012
    Date of Patent: September 2, 2014
    Assignee: Kold-Ban International, Ltd.
    Inventors: Dean Solberg, James Burke
  • Method for treating atrophic age related macular degeneration
    Patent number: 8821870
    Abstract: Compositions and methods for treating dry age related macular degeneration (dry AMD) by administration to an intraocular location of an anti-neovascular agent (such as bevacizumab) in either a liquid or solid polymeric vehicle (or both), such as a biodegradable hyaluronic acid or PLGA (or PLA).
    Type: Grant
    Filed: July 18, 2008
    Date of Patent: September 2, 2014
    Assignee: Allergan, Inc.
    Inventors: Michael R. Robinson, Wendy M. Blanda, Patrick M. Hughes, James A. Burke, Scott M. Whitcup
  • BIODEGRADABLE DRUG DELIVERY SYSTEMS FOR THE SUSTAINED RELEASE OF PROTEINS
    Publication number: 20140086974
    Abstract: Biodegradable drug delivery systems, such as extruded implants, for the sustained delivery of a protein to an ocular region of the eye or intraarticular region in the body are described. The drug delivery systems may be used to treat a variety of ocular and medical conditions, including macular degeneration. Methods for using and making the drug delivery systems are also described. The drug delivery systems can be in the form of extruded filaments configured for placement in an ocular region such as the vitreous body or anterior chamber of the eye.
    Type: Application
    Filed: September 26, 2013
    Publication date: March 27, 2014
    Inventors: Cindy W. Wu, Michael R. Robinson, James A. Burke, Patrick M. Hughes
  • INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS
    Publication number: 20140045945
    Abstract: Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye.
    Type: Application
    Filed: September 19, 2013
    Publication date: February 13, 2014
    Applicant: Allergan, Inc.
    Inventors: Michael R. Robinson, James A. Burke, Rhett M. Schiffman, Alazar N. Ghebremeskel
  • Intracameral sustained release therapeutic agent implants
    Patent number: 8647659
    Abstract: Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: February 11, 2014
    Assignee: Allergan, Inc.
    Inventors: Michael R. Robinson, James A. Burke, Rhett M. Schiffman, Alazar N. Ghebremeskel
  • ALPHA-2 AGONIST POLYMERIC DRUG DELIVERY SYSTEMS
    Publication number: 20140038972
    Abstract: Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants can be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, including reduction of an elevated intraocular pressure.
    Type: Application
    Filed: August 30, 2013
    Publication date: February 6, 2014
    Applicant: Allergan, Inc.
    Inventors: James N. Chang, Lon T. Spada, Wendy M. Blanda, Werhner C. Orilla, James A. Burke, Patrick M. Hughes
  • Compositions and Methods for Localized Therapy of the Eye
    Publication number: 20140031298
    Abstract: Compositions, and methods of using such compositions, useful for injection into the posterior segments of human or animal eyes are provided. Such compositions include small particles of a poorly soluble therapeutic agent that facilitates formation of concentrated regions of the therapeutic agent in the retinal pigmented epithelium of an eye. The particles are formed by combining a therapeutic agent with an ophthalmically acceptable polymer component. The particles have sizes less than about 3000 nanometers, and in some cases, less than about 200 nanometers. One example of a composition includes particles of triamcinolone acetonide and hyaluronic acid have a size less than about 3000 nanometers.
    Type: Application
    Filed: April 5, 2013
    Publication date: January 30, 2014
    Applicant: Allergan, Inc.
    Inventors: Patrick M. Hughes, Orest Olejnik, Scott M. Whitcup, James A. Burke
  • Sustained release intraocular implants and methods for preventing retinal dysfunction
    Patent number: 8609144
    Abstract: Biocompatible intraocular microspheres and implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat or to prevent the occurrence of one or more ocular conditions, to reduce one or more symptoms of an ocular condition, such as an ocular neurosensory disorder and the like, to enhance normal retinal function and/or to lower intraocular pressure.
    Type: Grant
    Filed: June 19, 2008
    Date of Patent: December 17, 2013
    Assignee: Allergan, Inc.
    Inventors: James Burke, Patrick M. Hughes, Orilla C. Werhner, Ton C. Lin, Maria Escobar, Glenn Huang, Kai-Ming Zhang, Larry A. Wheeler, Rosy S. Donn
  • Sustained release intraocular implants and methods for treating ocular vasculopathies
    Patent number: 8580292
    Abstract: Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, among others.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: November 12, 2013
    Assignee: Allergan, Inc.
    Inventors: Glenn T Huang, Brittany Jackson, James A. Burke, Ton Lin, Patrick M. Hughes, Larry A. Wheeler, Rosy Sheng Donn
  • Bearing arrangement for a telescopic axle
    Patent number: 8573846
    Abstract: An extendible axle member (146 or 148) is provided for a pivoting axle of an agricultural harvester (100), the extendible axle member (146 or 148) having an elongate telescopic portion (400) with bearing surfaces for being slidably received in an outer axle member (142 or 144), wherein the elongate telescopic portion (400) is formed integral with and abuts a C-frame for supporting a steering knuckle (158 or 160).
    Type: Grant
    Filed: May 5, 2010
    Date of Patent: November 5, 2013
    Assignee: Deere & Company
    Inventors: Ryan Patrick Mackin, Daniel James Burke, Bruce Alan Coers, Eric Alln Risius, Shane Anderson, David Rix
  • Sustained Release Intraocular Implants and Methods for Preventing Retinal Dysfunction
    Publication number: 20130236526
    Abstract: Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to prevent the occurrence of one or more ocular conditions, or to reduce one or more symptoms of an ocular condition, such as an ocular neurosensory disorder and the like.
    Type: Application
    Filed: April 22, 2013
    Publication date: September 12, 2013
    Applicant: Allergan, Inc.
    Inventors: Glenn T. Huang, James A. Burke, Patrick M. Hughes, Kai-Ming Zhang, Ton Lin, Larry A. Wheeler, Rosy Sheng
  • Alpha-2 agonist polymeric drug delivery systems
    Patent number: 8529927
    Abstract: Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants can be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, including reduction of an elevated intraocular pressure.
    Type: Grant
    Filed: March 31, 2006
    Date of Patent: September 10, 2013
    Assignee: Allergan, Inc.
    Inventors: James N. Chang, Lon T. Spada, Wendy M. Blanda, Werhner C. Orilla, James A. Burke, Patrick M. Hughes
  • SUPPLEMENTARY ENERGY STARTING SYSTEM INCORPORATING A TIMING CIRCUIT
    Publication number: 20130213336
    Abstract: An engine cranking system and a method of cranking an engine are provided. The engine cranking system comprises an engine, cranking motor, and capacitor. The engine cranking system further comprises an electrical path interconnecting the cranking motor or a battery to the capacitor. The engine cranking system further comprises a control circuit coupled to the capacitor. The control circuit comprises a timer operative to track temporal information. The control circuit is operative to apply a control voltage that varies in response to the tracked temporal information. The control circuit further comprises a relay included in the electrical path. The relay is operative to switch, in response to the control voltage, between an open-circuit condition, in which the relay interrupts the electrical path, and a closed-circuit condition.
    Type: Application
    Filed: February 20, 2012
    Publication date: August 22, 2013
    Inventors: Dean Solberg, James Burke
  • Sustained release intraocular implants and methods for treating ocular vasculopathies
    Patent number: 8506986
    Abstract: Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, among others.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: August 13, 2013
    Assignee: Allergan, Inc.
    Inventors: Glenn T Huang, Brittany Jackson, James A. Burke, Ton Lin, Patrick M. Hughes, Larry A. Wheeler, Rosy Sheng Donn